首页|sFlt-1基因阻断VEGF抑制小鼠骨肉瘤生长的机制研究

sFlt-1基因阻断VEGF抑制小鼠骨肉瘤生长的机制研究

扫码查看
目的 探讨可溶性血管内皮生长因子(VEGF)受体Flt-1(sFlt-1)与小鼠骨肉瘤生长的关系及其相关分子生物学机制.方法 通过逆转录病毒载体将sFlt-1和LacZ基因转导至人骨肉瘤G-292细胞,将其与未转导的G-292细胞分别移植到重度联合免疫缺陷小鼠胫骨近端建立骨肉瘤模型,实验分为G-292组、LacZ转导组、sFlt-1转导组和假手术组.第2、4、6和8周使用microCT监测肿瘤的发展,并在8周时收集肿瘤标本检测VEGF、sFlt-1、CD34、Ki-67、c-myc、c-fos、趋化因子受体4(CXCR4)表达;实时荧光定量聚合酶链式反应(qRT-PCR)检测c-myc和c-fos mRNA表达.结果 8周时sFlt-1 转导组肿瘤大小为(7.56±2.00)mm3,小于 LacZ 转导组[(28.28±6.85)mm3]和 G-292 组[(32.76± 10.06)mm3],F=17.789,P<0.001.肿瘤组织中sFlt-1转导组CD34阳性微血管密度为13.60±3.27,低于LacZ转导组(24.50±6.88)和 G-292 组(22.50±4.74),F=12.532,P<0.001.sFlt-1 转导组 c-myc 水平为 399.35±72.14,低于LacZ 转导组(672.35±108.74)及 G-292 组(640.11±91.43),F=115.623,P<0.001;sFlt-1 转导组 Ki-67 水平为 416.35± 37.92,低于 LacZ 转导组(872.25±87.75)及 G-292 组(896.15±80.61),F=412.285,P<0.001;sFlt-1 转导组 CXCR4水平为 400.57±13.38,低于 LacZ 转导组(1 024.75±63.60)及 G-292 组(960.34±60.20),F=1 033.337,P<0.001.sFlt-1 转导组 c-myc mRNA 表达水平为 5.42±0.74,低于 LacZ 转导组(7.60±1.14)及 G-292 组(8.06±1.26),F=17.380,P<0.001;c-fos mRNA 表达水平为 3.96±1.09,低于 LacZ 转导组(4.83±1.11)及 G-292 组(4.73±0.96),F=2.034,P=0.150.结论 sFlt-1基因转导抑制了小鼠骨肉瘤的生长.sFlt-1过表达可能通过抑制肿瘤内微血管发育和下调c-myc、Ki-67和CXCR4表达抑制VEGF功能.
Study on the mechanism of sFlt-1 gene blocking VEGF inhibits the growth of osteosarcoma in mice
Objective To explore the relationship between the soluble vegf receptor Flt-1(sFlt-1)and osteosarcoma growth and its possible molecular mechanism on a mouse osteosarcoma model.Methods sFlt-1 and LacZ genes were transduced into human osteosarcoma G-292 cells by retroviral vectors,and the transduced and untransduced G-292 cells were respec-tively transplanted into the proximal tibia of severe combined immunodeficiency mice to establish osteosarcoma models.The experiment was divided into G-292 group,LacZ transduction group,sFlt-1 transduction group and sham surgery group.The tumors were monitored by microCT at 2,4,6 and 8 weeks,and tumor specimens were collected at 8 weeks for detection of VEGF,sFlt-1,CD34,Ki-67,c-myc,c-fos,chemokine receptor 4(CXCR4)expression,and real-time fluorescence quantitative(qRT)-PCR for detection of c-myc and c-fos mRNA expression.Results At 8 weeks,the tumor size in sFlt-1 transduction group was(7.56±2.00)mm3,which was smaller than that in LacZ transduction group[(28.28± 6.85)mm3]and G-292 group[(32.76±10.06)mm3],F=17.789,P<0.001.The CD34-positive microvascular density in sFlt-1 transduction group was 13.60±3.27,which was lower than that in LacZ transduction group(24.50±6.88)and G-292 group(22.50±4.74),F=12.532,P<0.001.The level of c-myc in sFlt-1 transduction group was 399.35± 72.14,lower than that in LacZ transduction group(672.35±108.74)and G-292 group(640.11±91.43),F=115.623,P<0.001.Ki-67 level in sFlt-1 transduction group was 416.35±37.92,lower than that in LacZ transduction group(872.25±87.75)and G-292 group(896.15±80.61),F=412.285,P<0.001.The CXCR4 level in sFlt-1 transduction group was 400.57±13.38,lower than that in LacZ transduction group(1024.75±63.60)and G-292 group(960.34± 60.20),F=1 033.337,P<0.001.The expression level of c-myc mRNA in sFlt-1 transduction group was 5.42±0.74,lower than that in LacZ transduction group(7.60±1.14)and G-292 group(8.06±1.26),F=17.380,P<0.001.The mRNA expression level of c-fos was 3.96±1.09,which was lower than that of LacZ transduction group(4.83±1.11)and G-292 group(4.73±0.96),F=2.034,P=0.150.Conclusions sFlt-1 gene transduction inhibits the growth of os-teosarcoma in mice.Overexpression of sFlt-1 may inhibit VEGF function by inhibiting microvascular development in tumors and down-regulating the expression of c-myc,Ki-67 and CXCR4.

osteosarcomasoluble vascular endothelial growth factor receptorvascular endothelial growth factormicro-vascular density

宋文真、杨福俊、李宏达、王鹏、杨上游、殷德振

展开 >

滨州医学院第二临床医学院,山东 烟台 264033

威海市立医院肿瘤科,山东威海 264200

威海市立医院脊柱骨科,山东威海 264200

堪萨斯大学威奇塔医学院骨外科,美国堪萨斯州威奇塔市67214

展开 >

骨肉瘤 可溶性血管内皮生长因子受体 血管内皮生长因子 微血管密度

2024

中华肿瘤防治杂志
中华预防医学会 山东省肿瘤防治研究院

中华肿瘤防治杂志

CSTPCD北大核心
影响因子:1.292
ISSN:1673-5269
年,卷(期):2024.31(7)
  • 33